Acute Rheumatic Fever and Rheumatic Heart Disease is a concise, yet comprehensive, clinical resource highlighting must-know information on rheumatic heart disease and acute rheumatic fever from a global perspective. Covering the major issues dominating the field, this practical resource presents sufficient detail for a deep and thorough understanding of the latest treatment options, potential complications, and disease management strategies to improve patient outcomes. - Divided into four distinct sections for ease of navigation: Acute Rheumatic Fever, Rheumatic Heart Disease, Population-Based Strategies for Disease Control, and Acute and Emergency Presentations. - International editors and chapter authors ensure a truly global perspective. - Covers all clinical aspects, including epidemiology, pathophysiology, clinical features, diagnosis, management, and treatment. - Includes key topics on population-based measures for disease control for effective primary, secondary, and tertiary prevention. - Consolidates today's available information and guidance into a single, convenient resource.

This book provides a comprehensive guide to Acute Rheumatic Fever (ARF) and Chronic Rheumatic Heart Disease RHD). Beginning with a review of the history of these conditions, the text continues with a discussion on the pathology and diagnosis of both ARF and RHD, the role of echocardiography, management of the conditions, including during pregnancy; treatment and much more. The book is accompanied by a DVD of echocardiographic videos to assist in the detection and diagnosis of the diseases.

This book provides a comprehensive guide to Acute Rheumatic Fever (ARF) and Chronic Rheumatic Heart Disease RHD). Beginning with a review of the history of these conditions, the text continues with a discussion on the pathology and diagnosis of both ARF and RHD, the role of echocardiography, management of the conditions, including during pregnancy; treatment and much more. The book is accompanied by a DVD of echocardiographic videos to assist in the detection and diagnosis of the diseases.

Rheumatic heart disease presents a major public health challenge (particularly for children) and major determinants are poverty, malnutrition, overcrowding, poor housing and a shortage of health-care resources. Although cost effective prevention and control strategies are available, they remain underused in most developing countries. This publication contains the report of a WHO expert consultation, held in Geneva in October 2001, which reviewed the current scientific knowledge of rheumatic fever and rheumatic heart disease, as well as the medical and public health related practices. It suggests practical recommendations for an evidence-based approach to the prevention and management of the disease and for cost-effective programmes for their control.

Today rheumatic fever is still the most common cause of heart disease in children and young adults in developing countries. This disease is typically associated with poverty, in particular with poor housing, overcrowding and inadequate medical care. Rheumatic fever has almost disappeared from economically developed countries; this trend has paralleled improvements in standards of living. However, the recent resurgence of rheumatic fever in middle-class families in the U. S. A. has re-emphasized the importance of this disease in the developed countries as well. Prevention and control of rheumatic fever and rheumatic heart disease is an important part of the WHO cardiovascular disease program. Based on earlier WHO experience, and on the magnitude of the problem, it was realized that concerted action was needed to combat this significant cause of cardiovascular morbidity and mortality. The present program has been developed on the principle that sound knowledge and reliable technology already exist for implementing community programs for the prevention and control of rheumatic fever and rheumatic heart disease with the intention of extending activities toward nationwide coverage. The first edition of this book was an excellent instrument to assist in the control of this disease. The present volume with dissemination of knowledge to health personnel will contribute to closing the gap between knowledge and implementation and it links with WHO's endeavors in prevention and control of rheumatic fever and rheumatic heart disease.

1. Lessons Learnt from History of Rheumatic Heart Diseases 2. Rheumatic Fever and Rheumatic Heart Disease: A 4-century Review with Special Reference to India 3. Epidemiology of Group a Streptococcal Infections, Rheumatic Fever, and Rheumatic Heart Disease 4. Can We Change the Epidemiological Trend of Rheumatic Heart Disease in India? 5. Etiopathogenesis and Management of Streptococcal Infection 6. Laboratory Diagnosis of Group A B-hemolytic Streptococcal Infections 7. Etiopathogenesis and Pathology of Carditis in Rheumatic Fever 8. Pathology of Chronic Rheumatic Heart Disease 9. Etiopathogenesis, Clinical Manifestations, and Diagnosis of Acute Rheumatic Fever 10. Cardiac Complications of Acute Rheumatic Fever 11. Role of Echocardiography in Diagnosis of Carditis in Acute Rheumatic Fever 12. Clinical Profile of Rheumatic Heart Disease 13. Role of Echocardiography in Rheumatic Heart Disease 14. Consensus and Controversies in the Management of Acute Rheumatic Fever: Introducing Armor to Prevent and Protect 15. Medical Management of Rheumatic Heart Disease and Management during Pregnancy, Noncardiac Surgery, and Infective Endocarditis 16. Echocardiographic Screening for Rheumatic Heart Disease 17. Prevention and Vaccine for Rheumatic Fever: How Far are We? 18. Natural History of Rheumatic Fever and Rheumatic Heart Disease 19. Nonsurgical Management of Rheumatic Heart Disease 20. Transcatheter Treatment of Rheumatic Mitral Stenosis in Pediatric Age Group 21. Surgical Management of Rheumatic Heart Disease 22. Rheumatic Fever, Rheumatic Heart Disease Registry, and Control Program

The prevalence of autoimmune diseases and rheumatic conditions is constantly increasing. Autoimmune diseases affect approximately 7-10% of the population of the United States, while more than 50,000,000 American adults suffer from some type of arthritis. The Heart in Rheumatic, Autoimmune and Inflammatory Diseases examines the complex mechanisms relating to cardiac diseases from a pathophysiological and clinical point of view. Autoimmune rheumatic diseases can affect the coronary vessels, myocardium, pericardium, heart valves and the conduction system. The diagnosis of these unique cardiac complications necessitates medical awareness and a high index of suspicion. Increased risk of advanced atherosclerosis plays a pivotal role in the development of cardiac diseases in systemic, rheumatic and autoimmune illnesses. Yet, other complex immune medicated mechanisms may contribute to the pathogenesis. Patients' optimal care requires coordination between the primary caregiver, the rheumatologist, immunologist and cardiologist. Screening for cardiovascular risk factors, recognition of high-risk patients and identification of subclinical cardiac conditions are of great importance. Moreover, regulation of inflammation, as well as abnormal immune responses and the initiation of early treatments should be the focus of patient management. A continuous attempt to identify novel therapeutic targets and change the natural history of the underlying disease and its cardiac manifestations is in progress. The book aims at providing the readers with a state of the art collection of up to date information regarding clinically important topics based on experts' perspectives. This book was a result of an extended coordinated collaboration of one-hundred and fifty-four distinguished scientists from thirty-one countries around the globe. - A review of common, as well as unusual (yet clinically significant) medical cardiac complications of prevalent rheumatic, autoimmune and inflammatory diseases. - Focuses on aspects of pathophysiological processes, clinical presentations, screening tests, prognostic implications and novel therapeutic approaches. - Presents an up-to-date "level of evidence and "strengths of recommendations for suggested therapies and reviews all randomized clinical trials, meta-analyses and other supporting published clinical findings.

The Oxford Textbook of Medicine: Cardiovascular Disorders is selected from the cardiology section of the renowned Oxford Textbook of Medicine. An authoritative resource on heart disease and beautifully illustrated in full colour, it is an essential guide to best practice in managing and preventing a wide variety of cardiovascular disorders. Chapters on arrhythmias, acute coronary syndromes and cardiac surgery have been completely revised and updated, together with new chapters on blood vessels and the endothelium, cardiac physiology, syncope and palpitations, and cardio-renal syndrome. Heart failure and heart disease in pregnancy are thoroughly treated, while imaging chapters evaluate the latest techniques and illustrate all clinical features with detailed images. In 46 finely crafted chapters with clear essentials, experts in cardiovascular disease review the essentials of diagnosis, guidelines and practice and provide a wealth of practical advice for use in clinical situations. In addition, background information on epidemiology, pathogenesis and pathophysiology encourages a fuller understanding of conditions, and more than 350 full colour images help with diagnosis. This essential reference tool supports all medical professionals seeking a general outline of treatment and prevention of cardiovascular disorders, and fills the gap between undergraduate teaching texts and specialist texts for cardiologists. Cardiologists and general physicians will find it immensely valuable when diagnosing and managing heart disease in their day-to-day practice. It is also of usefor trainees in cardiology and general medicine, especiallythose interested in applied cardiovascular pathophysiology.

Feigin and Cherry's Textbook of Pediatric Infectious Diseases helps you put the very latest knowledge to work for your young patients with unparalleled coverage of everything from epidemiology, public health, and preventive medicine through clinical manifestations, diagnosis, treatment, and much more. Ideal for all physicians, whether in an office or hospital setting, Feigin and Cherry’s equips you with trusted answers to your most challenging clinical infectious disease questions. Meet your most difficult clinical challenges in pediatric infectious disease, including today’s more aggressive infectious and resistant strains as well as emerging and re-emerging diseases, with unmatched, comprehensive coverage of immunology, epidemiology, public health, preventive medicine, clinical manifestations, diagnosis, treatment, and much more. Find the answers you need quickly thanks to an organization both by organ system and by etiologic microorganism, allowing you to easily approach any topic from either direction.